Mgr. Daniel Filip
Research specialist - PhD student, Marek Mráz Research Group
Total number of publications: 35
2023
-
Transformace indolentního folikulární lymfomu v difuzní velkobuněčný B-lymfom – molekulární podstata „nádorové agresivity“
Klinická onkologie, year: 2023, volume: 36, edition: 4, DOI
-
Transkripční faktor FoxO1 v adaptaci chronické lymfocytární leukémie na cílenou léčbu.
Year: 2023, type: Conference abstract
2022
-
Adaptace buněk chronické lymfocytární leukémie na cílenou léčbu BCR inhibitory.
Year: 2022, type: Conference abstract
-
Diagnostická sada pro stanoveni prognózy folikulárního lymfomu s pomocí kvantifikace miRNA
Year: 2022
-
Modelling chronic lymphocytic leukaemia microenvironment.
Year: 2022, type: Conference abstract
-
The role of long non-coding RNAs in BCR-mediated CLL activation.
Year: 2022, type: Conference abstract
2021
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract
-
miR-29 influences CD40 signaling in chronic lymphocytic leukemia (CLL): and axis affected by BCR inhibitors.
Year: 2021, type: Conference abstract
-
miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors
Blood, year: 2021, volume: 137, edition: 18, DOI
-
miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR.
Year: 2021, type: Conference abstract